journal article·2026-07-27

ANGPTL4 Exacerbates Renal Injury in Diabetic Kidney Disease by Impairing Podocyte Lipophagy via Compromised Lysosomal Degradative Function

Xiaojing Liu, Shimin Jiang, Zhenkun Yang, Shunlai Shang, Jiayi Li, Guming Zou, Cheng Zhou, Wenge Li

Publisher page

Abstract

ABSTRACT Diabetic kidney disease (DKD) progression is closely linked to the loss of podocyte homeostasis, driven in part by intracellular lipid accumulation and impaired autophagic clearance. This study identifies angiopoietin‐like protein 4 (ANGPTL4) as a potential regulator of podocyte lipophagy in DKD. In renal biopsies from patients with DKD, ANGPTL4 is upregulated in podocytes, and its expression is associated with greater proteinuria and more rapid renal function decline. In immortalized human podocytes, exposure to high glucose and palmitic acid (HGPA) increases both intracellular and secreted ANGPTL4, impairs autophagic flux, and promotes lipid droplet accumulation. Mechanistically, ANGPTL4 overexpression reduces TFEB nuclear localization, increases lysosomal pH, and decreases cathepsin B and lysosomal acid lipase activities, consistent with impaired terminal lysosomal lipid degradation. Conversely, ANGPTL4 knockdown restores autophagic and lysosomal programs under HGPA conditions. Recombinant human N‐terminal ANGPTL4 fragment reproduces several TFEB‐localization, lysosomal, and lipophagic defects, whereas extracellular neutralization partially reverses these changes. Expression of constitutively active TFEB‐S211A restores lysosomal function and lipid clearance and attenuates profibrotic remodeling. Collectively, these findings support an ANGPTL4–TFEB‐associated lysosome–lipophagy pathway linking diabetic metabolic stress to defective lipid clearance and podocyte injury.
Source: crossref · Quality: baseline

Affiliations

Department of Nephrology China‐Japan Friendship Hospital Beijing China

China‐Japan Friendship Hospital (Institute of Clinical Medical Sciences) Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Health Science Center Peking University Beijing China

Funding

National Natural Science Foundation of China · China Health Promotion Foundation

References (79)

Show source-provided references
1. Changing Epidemiology of Type 2 Diabetes Mellitus and Associated Chronic Kidney Disease10.1038/nrneph.2015.173 ↗
2. Diabetic Nephropathy: Diagnosis, Prevention, and Treatment10.2337/diacare.28.1.164 ↗
3. Chronic Kidney Disease10.1038/s41572-024-00589-9 ↗
4. Mechanisms of Diabetic Kidney Disease and Established and Emerging Treatments10.1038/s41574-025-01171-3 ↗
5. A Review of the Latest Real‐World Evidence Studies in Diabetic Kidney Disease: What Have We Learned About Clinical Practice and the Clinical Effectiveness of Interventions?10.1111/dom.15710 ↗
6. Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes10.1016/j.jacc.2025.10.060 ↗
7. Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular‐Kidney‐Metabolic Disease: Pooled Participant‐Level Analysis of 3 Global Trials10.1016/j.jacc.2025.08.039 ↗
8. ARHGEF7 (β‐PIX) Is Required for the Maintenance of Podocyte Architecture and Glomerular Function10.1681/ASN.2019090982 ↗
9. Diabetic Kidney Disease: Act Now or Pay Later10.1038/nrneph.2010.10 ↗
10. SETDB2 Mitigates Podocyte Dysfunction in Diabetic Kidney Disease Through Epigenetic Silencing of SMAD310.1002/advs.202516984 ↗
11. Transcription Factor MafB in Podocytes Protects Against the Development of Focal Segmental Glomerulosclerosis10.1016/j.kint.2020.02.038 ↗
12. The Spectrum of Podocytopathies: A Unifying View of Glomerular Diseases10.1038/sj.ki.5002222 ↗
13. Activated Protein C Protects Against Diabetic Nephropathy by Inhibiting Endothelial and Podocyte Apoptosis10.1038/nm1667 ↗
14. Single‐Cell Multi‐Omic and Spatial Profiling of human Kidneys Implicates the Fibrotic Microenvironment in Kidney Disease Progression10.1038/s41588-024-01802-x ↗
15. Impaired Glycolysis‐Derived Serine Metabolism as a Key Driver of Podocyte Injury With Senescence10.1038/s41467-025-66850-1 ↗
16. Cell‐Cell Crosstalk in Kidney Health and Disease10.1038/s41581-025-01025-1 ↗
17. FGF4‐FGFR1 Signaling Promotes Podocyte Survival and Glomerular Function to Ameliorate Diabetic Kidney Disease in Male Mice10.1038/s41467-025-65978-4 ↗
18. Deficiency of Nuclear Receptor Coactivator 3 Aggravates Diabetic Kidney Disease by Impairing Podocyte Autophagy10.1002/advs.202308378 ↗
19. Dock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid Metabolism10.1002/advs.202306365 ↗
20. Prolonged Glucagon Exposure Rewires Lipid Oxidation and Drives Diabetic Kidney Disease Progression10.1038/s41467-025-63529-5 ↗
21. Angptl4 Upregulates Cholesterol Synthesis in Liver via Inhibition of LPL‐ and HL‐dependent Hepatic Cholesterol Uptake10.1161/ATVBAHA.107.151894 ↗
22. Characterization of the Fasting‐Induced Adipose Factor FIAF, a Novel Peroxisome Proliferator‐Activated Receptor Target Gene10.1074/jbc.M004029200 ↗
23. Targeting OxLDL‐Mediated CD36 + CAF Reprogramming Potentiates PD‐1 Immunotherapy in Osteosarcoma10.1186/s12943-025-02516-2 ↗
24. Hypertriglyceridaemia and Elevated Cardiovascular Risk: Will ANGPTL4 Inhibition Address Both?10.1093/cvr/cvaf250 ↗
25. Exploring Memory Function Beyond Immune Cells: ANGPTL4‐Mediated Memory Functions in Tissue Resident Stem Cells10.1002/advs.202307545 ↗
26. Podocyte‐Secreted Angiopoietin‐Like‐4 Mediates Proteinuria in Glucocorticoid‐Sensitive Nephrotic Syndrome10.1038/nm.2261 ↗
27. Circulating Angiopoietin‐Like 4 Links Proteinuria With Hypertriglyceridemia in Nephrotic Syndrome10.1038/nm.3396 ↗
28. Angiopoietin‐Like 4 Exacerbates Renal Tubular Epithelial Cell Pyroptosis in Acute Kidney Injury via Integrin β5/FAK Signaling Pathway10.1016/j.kint.2025.07.025 ↗
29. Advancing the Clinical Assessment of Glomerular Podocyte Pathology in Kidney Biopsies via Super‐Resolution Microscopy and Angiopoietin‐Like 4 Staining10.7150/thno.101498 ↗
30. Association of Genetic Polymorphisms of Angiopoietin‐Like 4 With Severity of Posttransplant Proteinuria in Kidney Allograft Recipients10.1016/j.trim.2016.11.002 ↗
31. Renal Angptl4 Is a Key Fibrogenic Molecule in Progressive Diabetic Kidney Disease10.1126/sciadv.adn6068 ↗
32. CD‐1 db/db Mice: A Novel Type 2 Diabetic Mouse Model With Progressive Kidney Fibrosis10.1111/jdi.13311 ↗
33. Genetic Insights into the Mechanisms of Proliferative Glomerulonephritis10.1172/JCI183090 ↗
34. Podocyte Proliferation and Differentiation in Glomerular Disease: Role of Cell‐Cycle Regulatory Proteins
35. Interplay of Energy Metabolism and Autophagy10.1080/15548627.2023.2247300 ↗
36. The Lipid Basis of Cell Death and Autophagy10.1080/15548627.2023.2259732 ↗
37. Berberine Protects Glomerular Podocytes via Inhibiting Drp1‐Mediated Mitochondrial Fission and Dysfunction10.7150/thno.30640 ↗
38. Autophagy in Diabetic Kidney Disease: Regulation, Pathological Role and Therapeutic Potential10.1007/s00018-017-2639-1 ↗
39. Proximal Tubule Autophagy Differs in Type 1 and 2 Diabetes10.1681/ASN.2018100983 ↗
40. Autophagy Is Involved in Mouse Kidney Development and Podocyte Differentiation Regulated by Notch Signalling10.1111/jcmm.13061 ↗
41. Circ‐0000953 Deficiency Exacerbates Podocyte Injury and Autophagy Disorder by Targeting Mir665‐3p‐Atg4b in Diabetic Nephropathy10.1080/15548627.2023.2286128 ↗
42. Autophagy in Kidney Homeostasis and Disease10.1038/s41581-020-0309-2 ↗
43. Organelle‐Specific Autophagy in Inflammatory Diseases: A Potential Therapeutic Target Underlying the Quality Control of Multiple Organelles10.1080/15548627.2020.1725377 ↗
44. Capsaicin Alleviates Autophagy‐Lysosomal Dysfunction via PPARA‐Mediated V‐ATPase Subunit ATP6V0E1 Signaling in 3xTg‐AD Mice
45. Podocalyxin‐Like Protein 1 Regulates Pluripotency Through the Cholesterol Biosynthesis Pathway10.1002/advs.202205451 ↗
46. METTL3‐Mediated m(6)A Modification of TIMP2 mRNA Promotes Podocyte Injury in Diabetic Nephropathy10.1016/j.ymthe.2022.01.002 ↗
47. Sirt6 Deficiency Exacerbates Podocyte Injury and Proteinuria Through Targeting Notch Signaling10.1038/s41467-017-00498-4 ↗
48. Emerging Role of Podocyte Autophagy in the Progression of Diabetic Nephropathy10.1080/15548627.2015.1115173 ↗
49. Protective Effect of the Tunneling Nanotube‐TNFAIP2/M‐sec System on Podocyte Autophagy in Diabetic Nephropathy10.1080/15548627.2022.2080382 ↗
50. Mechanisms and Implications of Podocyte Autophagy in Chronic Kidney Disease10.1152/ajprenal.00415.2023 ↗
51. Lipid Homeostasis in Diabetic Kidney Disease10.7150/ijbs.95216 ↗
52. CCDC92 Deficiency Ameliorates Podocyte Lipotoxicity in Diabetic Kidney Disease10.1016/j.metabol.2023.155724 ↗
53. Renal Tubular Epithelial IGFBP7 Interacts With PKM2 to Drive Renal Lipid Accumulation and Fibrosis10.1016/j.ymthe.2025.05.013 ↗
54. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy10.2337/db22-0680 ↗
55. Renal Tubule Ectopic Lipid Deposition in Diabetic Kidney Disease Rat Model and In Vitro Mechanism of Leptin Intervention10.1007/s13105-022-00874-9 ↗
56. Tubular Injury in Diabetic Kidney Disease: Molecular Mechanisms and Potential Therapeutic Perspectives10.3389/fendo.2023.1238927 ↗
57. Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism10.1016/j.cmet.2020.10.019 ↗
58. Hypertensive Pressure Mechanosensing Alone Triggers Lipid Droplet Accumulation and Transdifferentiation of Vascular Smooth Muscle Cells to Foam Cells10.1002/advs.202308686 ↗
59. A Role for Lipophagy in Atherosclerosis10.1038/s41569-023-00885-z ↗
60. Lipophagy Deficiency Exacerbates Ectopic Lipid Accumulation and Tubular Cells Injury in Diabetic Nephropathy10.1038/s41419-021-04326-y ↗
61. Metabolism: Let Them Eat Fat10.1038/477166a ↗
62. HSPA12A Impairs Lipophagy to Exaggerate Septic Cardiomyopathy by Promoting MTOR's Competition Against LC3‐II in Binding With PNPLA2
63. PNPLA3 is a Triglyceride Lipase That Mobilizes Polyunsaturated Fatty Acids to Facilitate Hepatic Secretion of Large‐Sized Very Low‐Density Lipoprotein10.1038/s41467-024-49224-x ↗
64. A Gene Network Regulating Lysosomal Biogenesis and Function10.1126/science.1174447 ↗
65. TFEB Links Autophagy to Lysosomal Biogenesis10.1126/science.1204592 ↗
66. MTORC1 Functions as a Transcriptional Regulator of Autophagy by Preventing Nuclear Transport of TFEB10.4161/auto.19653 ↗
67. Lysosomal LAMP Proteins Regulate Lysosomal pH by Direct Inhibition of the TMEM175 Channel10.1016/j.molcel.2023.06.004 ↗
68. Lysosomal Acid Lipase and Lipophagy Are Constitutive Negative Regulators of Glucose‐Stimulated Insulin Secretion From Pancreatic Beta Cells10.1007/s00125-013-3083-x ↗
69. α‐Lipoic Acid Ameliorates Arsenic‐Induced Lipid Disorders by Promoting Peroxisomal β‐Oxidation and Reducing Lipophagy in Chicken Hepatocyte10.1002/advs.202413255 ↗
70. Kidney Lipid Dysmetabolism and Lipid Droplet Accumulation in Chronic Kidney Disease10.1038/s41581-023-00741-w ↗
71. Nephrotic Syndrome: Components, Connections, and Angiopoietin‐Like 4‐Related Therapeutics10.1681/ASN.2014030267 ↗
72. Dual Role of Circulating Angiopoietin‐Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome10.1053/j.ajkd.2014.04.016 ↗
73. Angiopoietin‐Like 4 Based Therapeutics for Proteinuria and Kidney Disease10.3389/fphar.2014.00023 ↗
74. The Proteinuria—Hypertriglyceridemia Connection as a Basis for Novel Therapeutics for Nephrotic Syndrome10.1016/j.trsl.2014.06.004 ↗
75. Plasma ANGPTL‐4 is Associated With Obesity and Glucose Tolerance: Cross‐Sectional and Longitudinal Findings10.1002/mnfr.201800060 ↗
76. Hypoglycemia Induces Diabetic Macrovascular Endothelial Dysfunction via Endothelial Cell PANoptosis, Macrophage Polarization, and VSMC Fibrosis10.1002/advs.202414530 ↗
77. ANGPTL4 Stabilizes Atherosclerotic Plaques and Modulates the Phenotypic Transition of Vascular Smooth Muscle Cells Through KLF4 Downregulation10.1038/s12276-023-00937-x ↗
78. Helicobacter Pylori‐Induced Angiopoietin‐Like 4 Promotes Gastric Bacterial Colonization and Gastritis10.34133/research.0409 ↗
79. Live‐Cell Microscopy and Fluorescence‐Based Measurement of Luminal pH in Intracellular Organelles10.3389/fcell.2017.00071 ↗